期刊文献+

宜昌地区临床分离耐碳青酶烯类鲍氏不动杆菌的分子流行病学特征 被引量:1

Molecular epidemiological characteristics of carbapenem resistant Acinetobacter baumannii isolates in Yichang
原文传递
导出
摘要 目的了解宜昌地区临床分离耐碳青酶烯类鲍氏不动杆菌(CRAB)的耐药性,研究CRAB的分子流行病学特征,为CRAB感染的预防治疗及分子流行病学研究提供实验依据。方法分析宜昌地区4所综合医院2013年10月-2014年10月临床分离的CRAB 30株,双纸片增效法(DDST)筛选金属β-内酰胺酶(MBLs),PCR扩增OXA-23、OXA-24、OXA-51、OXA-58、IMP-1、IMP-2、VIM-1、VIM-2型碳青霉烯酶基因,阳性进行测序分析。结果监测的17种药物中,除对多黏菌素全部敏感外,对头孢哌酮/舒巴坦和米诺环素耐药率为26.7%和63.3%,对其他抗菌药物耐药率均>80.0%;1株MBLs为阳性,28株扩增OXA-23阳性,30株扩增OXA-51阳性,1株VIM-2阳性,未检出OXA-24、OXA-58、IMP-1、IMP-2、VIM-1基因。结论宜昌地区临床分离CRAB耐药十分严重,产OXA-23、OXA-51型碳青霉烯酶是鲍氏不动杆菌对碳青酶烯类药物耐药的重要机制,同时产VIM-2型金属β-内酰胺酶也不容忽视。 OBJECTIVE To survey antibiotic resistance of clinical isolates of carbapenem resistanct Acinetobacter baumannii(CRAB)in Yichang,and investigate molecular epidemiological characteristics of CRAB,so as to provide experimental evidence for the prevention and molecular epidemiology of CRAB infection.METHODS A total of 30 strains of CRAB from 4general hospitals in Yichang from Oct.2013 to Oct.2014 were analyzed.Double-disk synergy test(DDST)was used to detect metallo-β-lactamase(MBLs),PCR was used to amplify carbapenemase genes(including OXA-23,OXA-24,OXA-51,OXA-58,IMP-1,IMP-2,VIM-1and VIM-2),and the positive products were sequenced.RESULTS Of the 17 antibiotics tested,all strains were sensitive to polymyxin,the resistant rates to cefoperazone/sulbactam,minocycline were 26.7 % and 63.3%,and to other antibiotics were more than80.0%.One strain of MBL phenotype was positive.Totally 28 strains amplified blaOXA-23 gene and one amplified blaVIM-2gene.All the 30 strains were positive for the amplification of the OXA-51 gene,and no strain was found which carried OXA-24,OXA-58,IMP-1,IMP-2,or VIM-1gene.CONCLUSION Multiple drug resistance is serious problems in Yichang.Production of OXA-23 and OXA-51 carbapenemases is an important mechanism of resistance to carbapenem antibiotics,and VIM-2carbapenemases also cannot be ignored.
出处 《中华医院感染学杂志》 CAS CSCD 北大核心 2016年第19期4332-4335,共4页 Chinese Journal of Nosocomiology
基金 湖北省自然科学基金资助项目(2012FKB07501)
关键词 鲍氏不动杆菌 碳青霉烯酶 分子流行病学 特征 Acinetobacter baumannii Carbapenemase Molecular epidemiological Characteristics
  • 相关文献

参考文献14

  • 1Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 2Shibata N,Doi Y,Yamane K,et al.PCR typing of genetic determinants for metallo-beta-lactamases and integrases carried bygram-negative bacteria isolated in Japan,with focus on the class 3integron[J].J Clin Microbiol,2003,41(12):5407-5013.
  • 3Woodford N,Ellington MJ,Coelho JM,et al.Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp[J].Int J Antimicrob Agents,2006,27(4):351-353.
  • 4朱德妹,汪复,胡付品,蒋晓飞,倪语星,孙景勇,徐英春,张小江,胡云健,艾效曼,俞云松,杨青,孙自镛,陈中举,贾蓓,黄文祥,卓超,苏丹虹,魏莲花,吴玲,张朝霞,季萍,王传清,王爱敏,张泓,孔菁,徐元宏,沈继录,单斌,杜艳.2010年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2011,11(5):321-329. 被引量:651
  • 5胡付品,朱德妹,汪复,蒋晓飞,孙自镛,陈中举,胡志东,李金,谢轶,康梅,徐英春,张小江,张朝霞,季萍,王传清,王爱敏,倪语星,孙景勇,俞云松,林洁,储云卓,田素飞,徐元宏,沈继录,单斌,杜艳,卓超,苏丹虹,张泓,孔菁,魏莲花,吴玲,胡云建,艾效曼.2013年中国CHINET细菌耐药性监测[J].中国感染与化疗杂志,2014,14(5):365-374. 被引量:622
  • 6Alsultan AA,Evans BA,Elsayed EA,et al.High frequency of carbapenem-resistant Acinetobacter baumannii in patients with diabetes mellitus in Saudi Arabia[J].J Med Microbiol,2013,62(Pt 6):885-888.
  • 7Ushizawa H,Yahata Y,Endo T,et al.A epidemiological investigation of a nosocomial outbreak of multidrug-resistant Acinetobacter baumannii in a critical care center in Japan,2011-2012[J].Jpn J Infect Dis,2016,69(2):143-148.
  • 8Cakirlar FK,Ciftci IH,Gonullu N.OXA-type carbapenemases and susceptibility of colistin and tigecycline among carbapenem-resistant Acinetobacter Baumannii isolates from patients with bacteremia in turkey[J].Clin Lab,2015,61(7):741-747.
  • 9Mezzatesta ML,Trovato G,Gona F,et al.In vitro activity of tigecycline and comparators against carbapenem-susceptible andresistant Acinetobacter baumannii clinical isolates in Italy[J].Ann Clin Microbiol Antimicrob,2008(7):4.
  • 10RuppéE,Woerther PL,Barbier F.Mechanisms of antimicrobial resistance in gram-negative bacilli[J].Ann Intensive Care,2015,5(1):61.

二级参考文献28

  • 1Arias CA,Murray BE.Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med,2009,360(5):439-443.
  • 2Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20 Vol 30 No.1.
  • 3Clinical and Laboratory Standads Institute Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2010,M100-S20-U Vol 30 No 15.
  • 4Clinical Laboratory Standard Institute.Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria[S].Approved Guideline M45-A,Vol.26 No.19,2006.
  • 5Wang P,Hu FP,Xiong ZZ,et al.Susceptibility of ESBL-Producing nterobacteriaceae with the New CLSI Breakpoints[J].J Clin Microbiol,2011,49(6):3127-3131.
  • 6Yang Q,Wang H,Sun H,et al.Phenotypic and genotypic characterization of Enterobacteriaceae with decreased susceptibility to carbapenems:results from large hospital-based surveillance studies in China[J].Antimicrob Agents Chemother,2010,54(1):573-577.
  • 7Wang H.Guo P,Sun HL,et al.Molecular epidemiology of clinical isolates of carbapenem-resistant Acinerobacter spp from Chinese hospitals[J].Antimicrob Agents Chemother.2007,51(11):4022-4028.
  • 8Arias CA. Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge[J].N Engl J Med. 2009. 360(5): 439-443.
  • 9Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. Twentyfourth informational supplement. 2014. M100-S24 Vol 34 No. 1.
  • 10Hu F. Chen S. Xu X. et al. Emergence of carbapenem-resistant clinical Enterobacteriaceae isolates from a teaching hospital in Shanghai. China[J]. J Med Microbiol , 2012. 61 (Pr 1): 132- 136.

共引文献1231

同被引文献14

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部